Nexalin Technology Regains Nasdaq Minimum Bid Price Compliance

What Happened

• Nexalin Technology, Inc. announced in an 8-K (filed Oct 1, 2026) that Nasdaq has confirmed the company has regained compliance with Nasdaq Listing Rule 5550(a)(2), which requires a minimum closing bid price of $1.00 per share.
• The company previously received a Hearings Panel notice on Sept 25, 2026 granting continued listing provided Nexalin (1) demonstrate compliance with the $1.00 minimum bid price by Sept 28, 2026 (which it did) and (2) demonstrate compliance with the Nasdaq stockholders’ equity requirement of $2,500,000 by Jan 4, 2027.

Key Details

• Nasdaq rule addressed: Listing Rule 5550(a)(2) (Minimum Bid Price Requirement).
• Deadline to meet stockholders’ equity requirement (Nasdaq Listing Rule 5550(b)(1)): Jan 4, 2027; required equity level: $2,500,000.
• Company’s common stock will remain listed and traded on The Nasdaq Capital Market during the exception period while it works to meet the equity requirement.
• Company warned there is no assurance it will meet the equity requirement; failure to comply could result in delisting.

Why It Matters

• Regaining compliance with the $1.00 minimum bid price avoids immediate delisting and preserves trading on Nasdaq for now, which supports liquidity and investor access.
• The upcoming $2.5M stockholders’ equity requirement is the next material milestone — if Nexalin cannot demonstrate compliance by Jan 4, 2027, Nasdaq could delist the stock, which could significantly affect trading, visibility, and investor value.
• Retail investors should monitor Nexalin’s updates on equity improvements or capital actions that address the Jan 4, 2027 deadline.